Sarcopenia, a common complication of cirrhosis, has an incidence rate as high as 40% ~ 70%. Furthermore, adverse events such as shortened survival, lower quality of life, prolonged hospital stay, increased complications, a higher mortality rate, and sometimes altering the liver transplantation prognostic outcome in patients with liver cirrhosis are closely related. In recent years, some progress has been made in the research on the treatment of sarcopenia, but there is no clear treatment plan at present; thus, research and development by researchers and clinicians still need to be strengthened. This article briefly describes the relevant treatment methods for sarcopenia in patients with cirrhosis.
肌肉减少症作为肝硬化的一种常见并发症，其发病率高达40%～70%，且与肝硬化患者的生存期缩短、生活质量下降、住院时间延长、并发症发生率上升及死亡率上升等不良事件密切相关，有时还会影响肝移植的预后结局。近年来，有关肌肉减少症治疗方面的研究取得了一定的进展，但目前尚无明确的治疗方案，仍需要研究学者及临床医生加强研发。现将对肝硬化患者肌肉减少症的相关治疗方法进行简要阐述。.
Keywords: Liver cirrhosis; Malnutrition; Sarcopenia; Therapeutics.